Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Clinica Chimica Acta; International Journal of Clinical Chemistry
K NakajimaAkira Tanaka


Since Zilversmit first proposed postprandial lipemia as the most common risk of cardiovascular disease, chylomicrons (CM) and CM remnants have been thought to be the major lipoproteins which are increased in the postprandial hyperlipidemia. However, it has been shown over the last two decades that the major increase in the postprandial lipoproteins after food intake occurs in the very low density lipoprotein (VLDL) remnants (apoB-100 particles), not CM or CM remnants (apoB-48 particles). This finding was obtained using the following three analytical methods; isolation of remnant-like lipoprotein particles (RLP) with specific antibodies, separation and detection of lipoprotein subclasses by gel permeation HPLC and determination of apoB-48 in fractionated lipoproteins by a specific ELISA. The amount of the apoB-48 particles in the postprandial RLP is significantly less than the apoB-100 particles, and the particle sizes of apoB-48 and apoB-100 in RLP are very similar when analyzed by HPLC. Moreover, CM or CM remnants having a large amount of TG were not found in the postprandial RLP. Therefore, the major portion of the TG which is increased in the postprandial state is composed of VLDL remnants, which have been recognized as a si...Continue Reading


Sep 1, 1979·Circulation·D B Zilversmit
Jun 1, 1992·Journal of Internal Medicine·S S Fojo, H B Brewer
Oct 1, 1989·European Journal of Clinical Investigation·S M HaffnerW R Hazzard
Aug 1, 1987·Baillière's Clinical Endocrinology and Metabolism·J R Patsch
Apr 15, 1986·Biochimica Et Biophysica Acta·H Semb, T Olivecrona
Aug 1, 1981·Canadian Journal of Biochemistry·J L Vigne, R J Havel
Dec 1, 1982·The Journal of Clinical Investigation·I J GoldbergW V Brown
Apr 15, 1995·Thrombosis Research·R KnöflerA Takada
Apr 1, 1994·Current Opinion in Lipidology·R J Havel
Jan 1, 1994·Journal of Atherosclerosis and Thrombosis·K NakajimaT Murase
Jan 1, 1994·Journal of Atherosclerosis and Thrombosis·S TomonoK Nakajima
Jan 1, 1997·International Journal of Legal Medicine·S TakeichiK Nakajima
Dec 3, 1999·Journal of Internal Medicine·F Karpe
May 16, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·M OkazakiK Nakajima
Nov 22, 2000·Current Opinion in Lipidology·R J Havel
Feb 28, 2001·American Journal of Epidemiology·H IsoY Komachi
Jan 30, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shinichi UsuiMitsuyo Okazaki
Mar 18, 2003·Journal of Lipid Research·Samir S DeebJohn D Brunzell
Apr 3, 2003·Journal of Lipid Research·Naohiko SakaiYuji Matsuzawa
Apr 30, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Sanae TakeichiKatsuyuki Nakajima
Nov 27, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Makoto KinoshitaTamio Teramoto
Jan 13, 2005·Journal of Atherosclerosis and Thrombosis·Akira Tanaka
Feb 2, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katsuyuki NakajimaAkira Tanaka
Jul 25, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hiroshi OkamotoKatsuyuki Nakajima

❮ Previous
Next ❯


May 19, 2012·Current Opinion in Lipidology·Jing PangGerald F Watts
Nov 20, 2012·Current Opinion in Lipidology·Mary J Malloy, John P Kane
Jun 28, 2012·Journal of Lipid Research·Tomomi YamazakiOsamu Ezaki
Jan 10, 2013·PloS One·Lichun ZhouZhongmao Guo
Mar 29, 2014·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Timothy D HedenJohn P Thyfault
Feb 11, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Jan BorénMarja-Riitta Taskinen
Jun 22, 2014·Current Cardiology Reports·Alan A HennessyCatherine Stanton
Dec 3, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Toru MiyoshiHiroshi Ito
Mar 29, 2014·Current Medical Research and Opinion·Angela PirilloAlberico Luigi Catapano
Mar 18, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Rojeet ShresthaHitoshi Chiba
Sep 25, 2012·Heart Failure Clinics·Bernard P C Kok, David N Brindley
Feb 25, 2014·Molecular Aspects of Medicine·Albert K GroenFolkert Kuipers
Mar 22, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Katsuyuki NakajimaMasami Murakami
Dec 3, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Takashi ShirakawaMasami Murakami
Oct 14, 2016·Lipids in Health and Disease·Mohamed Abu-FarhaJehad Abubaker
Dec 3, 2016·Archives of Endocrinology and Metabolism·Raquel Cristina L A CoelhoJosefina Bressan
Mar 23, 2017·Journal of Atherosclerosis and Thrombosis·Takashi MiidaTamio Teramoto
Feb 3, 2018·Journal of Internal Medicine·Amanda J Berberich, Robert A Hegele
Oct 8, 2016·Food & Function·Jailane de Souza AquinoTânia Lúcia Montenegro Stamford
Apr 1, 2018·Journal of Biophotonics·Darya N ChernovaValeri P Maltsev
Aug 10, 2018·Aging and Disease·Carmen G VinagreRaul C Maranhão
Jun 24, 2018·Journal of the American Heart Association·Yehuda Handelsman, Norman E Lepor
Oct 1, 2017·Circulation Research·Jens B Simonsen
Jul 22, 2014·Circulation. Cardiovascular Genetics·Kimberly E ConnorsDustin S Hittel
Apr 18, 2013·Current Opinion in Cardiology·Genovefa Kolovou, Teik Chye Ooi
Jul 5, 2017·The Journal of Clinical Endocrinology and Metabolism·Teik Chye OoiDonna F Vine
Aug 29, 2019·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Paulina Gorzelak-PabiśMarlena Broncel
Mar 2, 2018·Current Opinion in Endocrinology, Diabetes, and Obesity·Katsuyuki Nakajima, Akira Tanaka
Apr 30, 2020·Angewandte Chemie·Jens B Simonsen, Rasmus Münter
Sep 20, 2017·Lipids in Health and Disease·Cintia Botelho DiasManohar L Garg
Dec 19, 2019·Journal of Clinical Medicine·Emma L SollyJoanne T M Tan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.